ArticleJournal of gastroenterology2026

Efficacy and safety of upadacitinib for Crohn's disease in patients in East Asia: a post hoc analysis of randomized phase 3 studies.

Minhu Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.